CELH
Celsius Holdings, Inc.
CELH has the edge over CPB overall, supported by stronger modeled upside and stronger fundamentals.
CPB
Campbell Soup Company
CPB trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CPB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weak |
CPB's revenue, profitability and cash flow are currently stable, but its balance sheet is weak.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over CPB in the historical PE scenario, which offers more potential upside but is not a forecast.
CPB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $14.62 | -34% |
| Forward | 13x | $22.07 | — |
| Fair | 16x | $21.33 | -3.4% |
| Current | 17x | $22.07 | — |
| Expensive | 21x | $27.55 | +25% |
Historical ranges are pointers, not guarantees.
CPB's PE is in its fair range at 17x. On analysts' estimates for next year's earnings, today's price would be 13x, in its cheap range.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over CPB on the outlook, with more favorable earnings and revenue expectations.
CPB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Stable | |
| Moderate | |
| Moderate |
Analysts expect CPB's earnings, revenue and profitability to hold roughly steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
CPB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.76 | +34% |
| Q3 2026 | $1.31 | -35% |
| Q2 2026 | $2.03 | +34% |
| Q1 2026 | $1.84 | +6.4% |
| Q4 2025 | $1.94 | +6% |
| Q3 2025 | $2.01 | +6.3% |
| Q2 2025 | $1.51 | -39% |
| Q1 2025 | $1.73 | -32% |
| Q4 2024 | $1.83 | -31% |
CPB has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over CPB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over CPB on profitability, with a higher operating margin.
CPB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.1B | -7.9% |
| Q2 2026 | $2.4B | -4.4% |
| Q1 2026 | $2.6B | -4.5% |
| Q4 2025 | $2.7B | -3.4% |
| Q3 2025 | $2.3B | +1.2% |
| Q2 2025 | $2.5B | +4.5% |
| Q1 2025 | $2.7B | +9.3% |
| Q4 2024 | $2.8B | +10% |
CPB's revenue has slid since its 2024 peak: $2.1B last quarter, down 7.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.2% | -11 points |
| Q2 2026 | 10% | +3.6 points |
| Q1 2026 | 11% | -1.5 points |
| Q4 2025 | 13% | -0.7 points |
| Q3 2025 | 12% | +8.2 points |
| Q2 2025 | 6.5% | -4 points |
| Q1 2025 | 12% | -0.7 points |
| Q4 2024 | 13% | -1 points |
CPB's operating margin was 0.2% last quarter, down 11 points from the same quarter a year ago, near the bottom of its range since 2019.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over CPB on cash flow, with stronger typical year-over-year growth.
CPB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $136M | +5.4% |
| Q2 2026 | $29M | -42% |
| Q1 2026 | $416M | +1.2% |
| Q4 2025 | $97M | -16% |
| Q3 2025 | $129M | -12% |
| Q2 2025 | $50M | -50% |
| Q1 2025 | $411M | +5.4% |
| Q4 2024 | $115M | +271% |
CPB's free cash flow has been positive every quarter for seven years: $678M over the past year, down 3.8% from the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over CPB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
CPB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +1M shares |
| 1 year | 0% | -- |
| 3 years | -0.3% | -1M shares |
| 5 years | -1.6% | -5M shares |
| Available history | -1% | -3M shares |
CPB has 300M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $2M |
| Q4 2025 | $24M |
| Q3 2025 | $2M |
| Q2 2025 | $4M |
| Q1 2025 | $2M |
| Q4 2024 | $54M |
CPB spent $26M buying back its own shares over the past year, down 58% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over CPB on leverage, with a lower net debt burden relative to earnings.
CPB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.3x | High |
| Q2 2026 | 4.3x | High |
| Q1 2026 | 4.5x | High |
| Q4 2025 | 4.5x | High |
| Q3 2025 | 4.3x | High |
| Q2 2025 | 4.9x | High |
| Q1 2025 | 4.7x | High |
| Q4 2024 | 5.0x | High |
CPB's net debt is about 5.3 years of its operating earnings (EBITDA), up from 4.3 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
CPB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.4 | Neutral |
| Stochastic | 63.7 | Neutral |
CPB's weekly RSI is 50 (neutral) and its Stochastic is 64 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
CPB PE vs Consumer Defensive Sector
| Metric | CPB | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 19x | 14% below |
| PE % | 55 | 18 | 37 pts above |
CPB has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
CPB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.7 | 6.7% above |
| 20 week MA | $21.7 | 1.8% above |
| 50 week MA | $23.2 | 5% below |
| 100 week MA | $29.1 | 24% below |
| 200 week MA | $37.7 | 41% below |
CPB has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 41% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
CPB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $49.5 | $48.6 | -1.8% |
| 2021 | $48.6 | $42.0 | -14% |
| 2022 | $42.0 | $57.3 | +37% |
| 2023 | $57.3 | $43.2 | -25% |
| 2024 | $43.2 | $41.8 | -3.3% |
| 2025 | $41.8 | $28.2 | -33% |
| 2026 YTD | $28.2 | $22.1 | -22% |
CPB has the edge over CELH on returns for 2026, with the stronger performance.